Overview

TCM in the Treatment of Lung Adenocarcinoma

Status:
Not yet recruiting

Trial end date:
2022-06-30

Target enrollment:

Participant gender:

Summary

This study is to evaluate the efficacy and safety of Jin-yuan-kang granule in the treatment of lung adenocarcinoma (LUAD) preliminarily, and provide reference for further study.

Phase:

N/A

Details

Lead Sponsor:

Henan University of Traditional Chinese Medicine